Search - tctmd.com

Displaying 121 - 140 of 595

Sort: Relevancy | Date

More Trial Evidence Supports Tenecteplase for Acute Stroke Thrombolysis

News Conference News ESOC 2024

More Trial Evidence Supports Tenecteplase for Acute Stroke Thrombolysis

May 21, 2024

Colchicine Misses in Secondary Stroke Prevention, but Door Not Closed Yet

News Conference News ESOC 2024

Colchicine Misses in Secondary Stroke Prevention, but Door Not Closed Yet

May 16, 2024

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

News Conference News ESC Heart Failure 2024

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

Michael O'Riordan

May 13, 2024

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

News Daily News

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Michael O'Riordan

May 07, 2024

Very Elderly Benefit From High-Intensity Lipid-Lowering After Acute MI

News Daily News

Very Elderly Benefit From High-Intensity Lipid-Lowering After Acute MI

Michael O'Riordan

May 02, 2024

Statins Might Help in HFpEF—Even in the Absence of ASCVD

News Daily News

Statins Might Help in HFpEF—Even in the Absence of ASCVD

May 01, 2024

May 2024 Dispatch for the CV Team

News Opinion CV Team Dispatch

May 2024 Dispatch for the CV Team

May 01, 2024

Keeping Systolic BP Below 130 May Help Women Live Into Their 90s: WHI Data

News Daily News

Keeping Systolic BP Below 130 May Help Women Live Into Their 90s: WHI Data

April 26, 2024

Balancing Hypertension and Fall Risk: A Delicate Dance in Elderly Patients

News Daily News

Balancing Hypertension and Fall Risk: A Delicate Dance in Elderly Patients

April 22, 2024

Lp(a) Linked to Higher ASCVD Risks in Diverse Patient Groups

News Daily News

Lp(a) Linked to Higher ASCVD Risks in Diverse Patient Groups

Michael O'Riordan

April 17, 2024

Triglyceride-Lowering Therapies Provide Favorable Outcomes in Early Testing

News Conference News ACC 2024

Triglyceride-Lowering Therapies Provide Favorable Outcomes in Early Testing

Michael O'Riordan

April 12, 2024

KARDIA-2: Zilebesiran Drops BP on Top of Common Antihypertensives

News Conference News ACC 2024

KARDIA-2: Zilebesiran Drops BP on Top of Common Antihypertensives

April 11, 2024

PROACT: Can we prevent chemotherapy-related heart damage in patients with breast cancer and lymphoma?

Presentation ACC 2024

PROACT: Can we prevent chemotherapy-related heart damage in patients with breast cancer and lymphoma?

Presenter: David Austin

April 08, 2024

Faster CAC Progression After Menopause May Warrant Intensified Therapy

News Conference News ACC 2024

Faster CAC Progression After Menopause May Warrant Intensified Therapy

April 04, 2024

April 2024 Dispatch for the CV Team

News Opinion CV Team Dispatch

April 2024 Dispatch for the CV Team

April 01, 2024

Icosapent Ethyl Lowers CV Risk Across Lp(a) Range: REDUCE-IT

News Conference News ACC 2024

Icosapent Ethyl Lowers CV Risk Across Lp(a) Range: REDUCE-IT

March 27, 2024

Peer Coaching May Help With BP Control in Rural Black Populations

News Daily News

Peer Coaching May Help With BP Control in Rural Black Populations

March 22, 2024

March 2024 Dispatch for the CV Team

News Opinion CV Team Dispatch

March 2024 Dispatch for the CV Team

March 01, 2024

High Lp(a) Levels Harmful in Patients With and Without ASCVD

News Daily News

High Lp(a) Levels Harmful in Patients With and Without ASCVD

Michael O'Riordan

February 27, 2024

Speedier Anticoagulation Reversal Tied to Better ICH Outcomes

News Conference News ISC 2024

Speedier Anticoagulation Reversal Tied to Better ICH Outcomes

February 15, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.